Brief: Enorama Pharma Q1 Net Sales Up At 449 Ksek
21/05/2025 07:51
May 21 (Reuters) - Enorama Pharma AB ERMA.ST: Q1 NET SALES AMOUNTED TO 449 KSEK Q1 OPERATING LOSS -16,678 KSEK IMPACTED BY INVENTORY WRITE-DOWN Source text: ID:nWkr2MyyBX Further company coverage: ERMA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO